Back
Speaker illustration

Ms Parisa Danaietash

Idorsia Pharmaceuticals, Allschwil (Switzerland)

Presentations

Efficacy and safety of various doses of the new dual endothelin receptor antagonist aprocitentan in the treatment of hypertension

Event: ESC Congress 2019

Topic: Treatment

Session: Drug treatment in hypertension - New insights

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources